BMRN

NASDAQ · Biotechnology

Biomarin Pharmaceutical Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$54.09

-0.69 (-1.26%)

As of Mar 24, 9:45 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 25 78%

Hold 7 22%

Sell 0 0%

Price Target

Analyst Price Target +133.8% upside

Low Target $89.21

Average Target $126.44

High Target $194.19

Current Price $54.09

Current
$54.09

Target
$126.44

$89.21 $126.44 avg $194.19

Scenario Analysis

Bear Case

$89.21

64.9%

Low target

Base Case

$126.44

+133.8%

Avg target

Bull Case

$194.19

+259.0%

High target

Risk/Reward

4.0x

Highly favorable

Price in Context

52-Week High

$73.51

-26.4% from high

52-Week Low

$50.76

+6.6% from low

50-Day SMA

$57.48

-5.9% vs SMA

200-Day SMA

$56.51

-4.3% vs SMA

RSI (14)

80.7

Overbought

Target vs 52W High

$126.44

+72.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+25.5%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.2%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-66.8%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	+3.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-26.5%